Phase IB trial of ACY-1215 (Ricolinostat) combined with nab-paclitaxel in metastatic breast cancer.

Kalinsky, K; Onishi, M; Yu, JY; Trivedi, MS; Accordino, MK; Crew, KD

JOURNAL OF CLINICAL ONCOLOGY, 2018; 36 (15):